GSK
Uniting science technology talent
- B2B
- B2C
- Has physical offices
- Publicly traded
- Manufacturing
- Multi-product
- Sales-led purchase
About GSK
Uniting science, technology, and talent to advance healthcare and disease prevention through collaborative innovation and community engagement.
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,000+ employees
- Headquarters
- london, england, United Kingdom
- Revenue
- £32.7BFY2025, publicly reported
- SIREN
- 642041362
- Website
- gsk.com
- linkedin.com/company/gsk
GSK competitors
Jobs at GSK
- ViiV Healthcare (GSK) Associate Director, Field Reimbursement Corporate Account, NYC North
- Medical Science Liaison (MSL) - Vaccines | NSW
- Specialty Account Specialist (Immunology) - Pittsburgh, PA
- Scientist, Formulation
- Stage en alternance : Gestion de Projet en Production de vaccins, Belgique - 2026
- HR Business Partner - US Commercial
- Hybrid Immunization Specialist (Vaccines) Quincy/Springfield, IL
- Director, AI/ML MIDD Oncology Clinical Pharmacology, Modeling and Simulation
GSK in the news
- AN2 Therapeutics Secures Extended Gates Foundation Funding For GSK Tuberculosis Collaboration
AN2 Therapeutics received extended funding from the Gates Foundation to continue its collaboration with GSK on developing boron-based LeuRS inhibitors for tuberculosis treatment.
- GSK stock reports Q2 sales growth despite profit hit
GSK experienced Q2 sales growth, but profit declined sharply due to significant impairment charges.
- Can FTSE 100 Drugmaker (LSE:GSK) Turn Its Nuvalent Acquisition Into A Fresh Growth Engine After This Week's Deal News?
GSK acquires Nuvalent, a US oncology specialist, for its lung cancer assets to boost future revenue growth and offset patent expirations.
- GSK’s Regional President Mike Crichton on leading winning teams from Singapore
GSK's Regional President for Greater China and Intercontinental discusses the company's long-standing presence and strategic investments in Singapore, highlighting its role as a key hub for talent, manufacturing, and market access in Asia.
- GSK agrees to acquire myeloma therapy. GSK stock costs EUR 20.83
GSK acquired a trispecific T-cell engager from Chimagen Biosciences for up to USD 750 million to develop a multiple myeloma treatment.
GSK at a glance
GSK is a B2B/B2C company in the Pharmaceutical Manufacturing industry, headquartered in london, england, United Kingdom.
GSK has 10,000+ employees.
GSK's revenue is £32.7B (FY2025, publicly reported).
GSK's SIREN number is 642041362.
GSK is hiring: 8 recent open roles, including ViiV Healthcare (GSK) Associate Director, Field Reimbursement Corporate Account, NYC North, Medical Science Liaison (MSL) - Vaccines | NSW, Specialty Account Specialist (Immunology) - Pittsburgh, PA.
Selling to companies like GSK?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies